@article{wils:hal-01214012,
TITLE = {Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents},
AUTHOR = {Wils, Pauline and Bouhnik, Yoram and Michetti, Pierre and Flourie, Bernard and Brixi, Hedia and Bourrier, Anne and Allez, Matthieu and Duclos, Bernard and Grimaud, Jean-Charles and Buisson, Anthony and Amiot, Aurelien and Fumery, Mathurin and Roblin, Xavier and Peyrin-Biroulet, Laurent and Filippi, Jer{\^o}me and Bouguen, Guillaume and Abitbol, Vered and Coffin, Benoit and Simon, Marion and Laharie, David and Pariente, Benjamin},
URL = {https://univ-rennes.hal.science/hal-01214012},
JOURNAL = {Clinical Gastroenterology and Hepatology},
PUBLISHER = {WB Saunders},
VOLUME = {14},
NUMBER = {2},
PAGES = {242--250.e2},
YEAR = {2016},
DOI = {10.1016/j.cgh.2015.09.018},
KEYWORDS = {IL12 ; IL23 ; immunosuppressant ; inflammatory bowel disease},
PDF = {https://univ-rennes.hal.science/hal-01214012/file/Subcutaneous%20Ustekinumab.pdf},
HAL_ID = {hal-01214012},
HAL_VERSION = {v1},
}